Unichem Laboratories

Stocks to Watch today, August 30, 2023: Billionaire Sunil Mittal's backed telecom services provider Airtel Uganda Ltd plans to raise $216 million in an initial public offering (IPO)

Unichem's facilities are compliant with US regulations, but it posted losses for nine months of FY23

Brokerages believe the acquisition is expensive, given increased competition in the US generics oral solids space, rising regulatory risks and strong efforts needed to turnaround Unichem Labs

The shares will be purchased at the cost of Rs 440 per share post the approval from the Competition Commission of India under the Competition Act, 2002

In the past three months, Unichem Labs has received abbreviated new drug application (ANDA) approvals for four drugs from the United States Food and Drug Administration (USFDA)

Stocks to Watch: Harsha Engineers will make its debut on the bourses today. The issue price is fixed at Rs 330 per share. As per IPO Watch, the stock can list with a 50 per cent premium

Unichem Laboratories on Wednesday said it has received approval from the US health regulator to market its generic version of Nebivolol tablets indicated for the treatment of hypertension

Aurobindo Pharma and Unichem Laboratories are recalling different products in the US market, the world's largest market for medicines, due to manufacturing issues. As per the latest enforcement report issued by the US Food and Drug Administration (USFDA), Aurobindo's US-based unit is recalling 7,296 containers of hypertension drug Carvedilol tablets. The affected lot contains 6.25 mg Carvedilol tablets, which have been produced in India and distributed in the US by Princeton-based Aurobindo Pharma USA Inc. The company is recalling the lot due to "failed impurities/degradation specifications", the US health regulator noted in the report. Aurobindo initiated the nationwide the recall on November 15 this year, it added. Another domestic drug maker Unichem Laboratories is recalling 1,284 bottles of Topiramate tablets, used to treat epilepsy (seizures) and to prevent migraines. It is also used in the treatment of Lennox-Gastaut syndrome (a rare, but severe form of epilepsy that starts

The tolterodine tartrate tablets are generic versions of Pfizer Inc's DETROL tablets

The specified batch, which is being recalled, has been manufactured at Unichem's Goa-based facility

Market Wrap, May 15: Here's all that happened in the markets today

Of 30 constituents, 20 declined and 10 advanced. Mahindra & Mahindra ended as the top loser on the index while telecom major Bharti Airtel was the biggest gainer

The company's tablets are a generic version of Bristol-Myers Squibb Company's Buspar tablets in the same strengths

Unichem said the product will be commercialised from its Ghaziabad, Uttar Pradesh, plant

The stock surged 9% to Rs 283 after the company said it has not received any observations from the US health regulator following completion of inspection of the company's facility in Ghaziabad, UP.

The stock dipped 9% to Rs 344 on BSE in intra-day trade after the stock of pharmaceutical company turned ex-share buyback today.

Shares of Unichem Laboratories on Monday closed at Rs 369.25 per scrip on BSE, up 5%

To give shareholders half the proceeds from sale of domestic business to Torrent

The stock hit a record high of Rs 339, up 12%, extending its past four days rally on the BSE.

The stock was trading 3% higher at Rs 315, extending its past two days 17% surge on the BSE

Total income up 16% to Rs 360 crore